Deborah Weitzman - 01 Dec 2025 Form 4 Insider Report for CARDINAL HEALTH INC (CAH)

Reporting relationship: CEO, PSS Segment
Issuer ticker: CAH
Reported as of: 01 Dec 2025
Net transaction value: -$116,955
SEC form: 4
Accepted by SEC: 02 Dec 2025, 16:11:35 UTC
Prior SEC filing: 20 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ James E. Barnett, Attorney-in-fact

Key filing fact

Deborah Weitzman filed Form 4 for CARDINAL HEALTH INC (CAH) on 02 Dec 2025.

Key facts

This page summarizes Deborah Weitzman's Form 4 filing for CARDINAL HEALTH INC (CAH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Dec 2025, 16:11.

Change

Previous filing in this sequence was filed on 20 Aug 2025.
Current net transaction value: -$116,955.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001942639 Primary reporting owner

WEITZMAN DEBORAH

Relationship: CEO, PSS Segment
Address: 7000 CARDINAL PLACE, DUBLIN
Signature: /s/ James E. Barnett, Attorney-in-fact
Signature date: 02 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAH transaction

Common Shares

Tax liability

Transaction value: $116,955
Shares: -551
Change %: -1%
Price: $212.26
Shares after: 52,877
Date: 01 Dec 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units.

Footnote F2

Price is closing share price on prior business day.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .